Cochlear implantation in common forms of genetic deafness

International Journal of Pediatric Otorhinolaryngology

Volumn 74, Issue 10, 2010, Pages 1107-1112

  Vivero, Richard J ^a   Fan, Kenneth ^a   Angeli, Simon ^a   Balkany, Thomas J ^a   Liu, Xue Z ^a  

^a UNIVERSITY OF MIAMI EAR INSTITUTE   (United States)

Author keywords

Cochlear implantation; Genetic deafness; GJB2; GJB3; Hearing loss; Jervell and Lange Nielson; Usher syndrome; Wardenburg syndrome

Indexed keywords

CONNEXIN 26; CONNEXIN 30; MITOCHONDRIAL DNA;

CELL SURVIVAL; COCHLEA PROSTHESIS; DISEASE SEVERITY; ELECTRORETINOGRAPHY; GENE LOCUS; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEARING LOSS; HEREDITY; HUMAN; IMPLANTATION; LONG QT SYNDROME; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; SPIRAL GANGLION; TREATMENT OUTCOME; USHER SYNDROME; WAARDENBURG SYNDROME;

COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; HEARING LOSS; HUMANS; TEMPORAL BONE;

EID: 77956474070     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.06.010     Document Type: Review

References (77)

1. National Center for Hearing Assessment and Management. http://www.infanthearing.org/.
2. Morton N.E. Genetic epidemiology of hearing impairment. Ann. NY Acad. Sci. 1991, 630:16-31.
3. Marazita M.L., Ploughman L.M., Rawlings B., Remington E., Arnos K.S., Nance W.E. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am. J. Med. Genet. 1993, 46(5):486-491.
4. Guilford P., Ben Arab S., Blanchard S., Levilliers J., Weissenbach J., Belkahia A., et al. A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat. Genet. 1994, 6(1):24-28.
5. Kelsell D.P., Dunlop J., Stevens H.P., Lench N.J., Liang J.N., Parry G., et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997, 387(6628):80-83.
6. Nickel R., Forge A. Gap junctions and connexins in the inner ear: their roles in homeostasis and deafness. Curr. Opin. Otolaryngol. Head Neck Surg. 2008, 16(5):452-457.
7. Snoeckx R.L., Huygen P.L., Feldmann D., Marlin S., Denoyelle F., Waligora J., et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am. J. Hum. Genet. 2005, 77(6):945-957.
8. Wiley S., Choo D., Meinzen-Derr J., Hilbert L., Greinwald J. GJB2 mutations and additional disabilities in a pediatric cochlear implant population. Int. J. Pediatr. Otorhinolaryngol. 2006, 70(3):493-500.
9. Denoyelle F., Marlin S., Weil D., Moatti L., Chauvin P., Garabédian E.N., et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 1999, 353(9161):1298-1303.
10. Propst E.J., Papsin B.C., Stockley T.L., Harrison R.V., Gordon K.A. Auditory responses in cochlear implant users with and without GJB2 deafness. Laryngoscope 2006, 116(2):317-327.
11. Beltramello M., Piazza V., Bukauskas F.F., Pozzan T., Mammano F. Impaired permeability to ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness. Nat. Cell Biol. 2005, 7(1):63-69.
12. Casademont I., Chevrier D., Denoyelle F., Petit C., Guesdon J.L. A simple and reliable method for the detection of the 30delG mutation of the CX26 gene. Mol. Cell. Probes 2000, 14(3):149-152.
13. Angeli S.I. Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. Laryngoscope 2008, 118(11):2014-2023.
14. Connell S.S., Angeli S.I., Suarez H., Hodges A.V., Balkany T.J., Liu X.Z. Performance after cochlear implantation in DFNB1 patients. Otolaryngol. Head Neck Surg. 2007, 137(4):596-602.
15. Cullen R.D., Buchman C.A., Brown C.J., Copeland B.J., Zdanski C., Pillsbury H.C., et al. Cochlear implantation for children with GJB2-related deafness. Laryngoscope 2004, 114(8):1415-1419.
16. Bauer P.W., Geers A.E., Brenner C., Moog J.S., Smith R.J. The effect of GJB2 allele variants on performance after cochlear implantation. Laryngoscope 2003, 113(12):2135-2140.
17. Green G.E., Scott D.A., McDonald J.M., Teagle H.F., Tomblin B.J., Spencer L.J., et al. Performance of cochlear implant recipients with GJB2-related deafness. Am. J. Med. Genet. 2002, 109(3):167-170.
18. Matsushiro N., Doi K., Fuse Y., Nagai K., Yamamoto K., Iwaki T., et al. Successful cochlear implantation in prelingual profound deafness resulting from the common 233delC mutation of the GJB2 gene in the Japanese. Laryngoscope 2002, 112(2):255-261.
19. Liu X.Z., Pandya A., Angeli S., Telischi F.F., Arnos K.S., Nance W.E., et al. Audiological features of GJB2 (connexin 26) deafness. Ear Hear 2005, 26(3):361-369.
20. Mesolella M., Tranchino G., Nardone M., Motta S., Galli V. Connexin 26 mutations in nonsyndromic autosomal recessive hearing loss: speech and hearing rehabilitation. Int. J. Pediatr. Otorhinolaryngol. 2004, 68(8):995-1005.
21. Fukushima K., Sugata K., Kasai N., Fukuda S., Nagayasu R., Toida N., et al. Better speech performance in cochlear implant patients with GJB2-related deafness. Int. J. Pediatr. Otorhinolaryngol. 2002, 62(2):151-157.
22. Sinnathuray A.R., Toner J.G., Clarke-Lyttle J., Geddis A., Patterson C.C., Hughes A.E. Connexin 26 (GJB2) gene-related deafness and speech intelligibility after cochlear implantation. Otol. Neurotol. 2004, 25(6):935-942.
23. Sinnathuray A.R., Toner J.G., Geddis A., Clarke-Lyttle J., Patterson C.C., Hughes A.E. Auditory perception and speech discrimination after cochlear implantation in patients with connexin 26 (GJB2) gene-related deafness. Otol. Neurotol. 2004, 25(6):930-934.
24. Dalamón V., Lotersztein V., Lipovsek M., Bèherán A., Mondino M.E., Diamante F., et al. Performance of speech perception after cochlear implantation in DFNB1 patients. Acta Otolaryngol. 2009, 129(4):395-398.
25. Azaiez H., Smith R.J In reference to temporal bone imaging in GJB2 deafness. Laryngoscope 2007, 117(6):1127. author reply 1127-1129.
26. Jun A.I., McGuirt W.T., Hinojosa R., Green G.E., Fischel-Ghodsian N., Smith R.J. Temporal bone histopathology in connexin 26-related hearing loss. Laryngoscope 2000, 110(2 Pt 1):269-275.
27. Mets M.B., Young N.M., Pass A., Lasky J.B. Early diagnosis of Usher syndrome in children. Trans. Am. Ophthalmol. Soc. 2000, 98:237-242. discussion 243-245.
28. Smith R.J., Berlin C.I., Hejtmancik J.F., Keats B.J., Kimberling W.J., Lewis R.A., et al. Clinical diagnosis of the Usher syndromes. Usher syndrome consortium. Am. J. Med. Genet. 1994, 50(1):32-38.
29. Kochhar A., Hildebrand M.S., Smith R.J. Clinical aspects of hereditary hearing loss. Genet. Med. 2007, 9(7):393-408.
30. Rosenberg T., Haim M., Hauch A.M., Parving A. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin. Genet. 1997, 51(5):314-321.
31. Yan D., Liu X.Z. Genetics and pathological mechanisms of Usher syndrome. J. Hum. Genet. 2010, 55(6):327-335.
32. Loundon N., Marlin S., Busquet D., Denoyelle F., Roger G., Renaud F., et al. Usher syndrome and cochlear implantation. Otol. Neurotol. 2003, 24(2):216-221.
33. Liu X.Z., Angeli S.I., Rajput K., Yan D, Hodges A.V, Eshraghi A, et al. Cochlear implantation in individuals with Usher type 1 syndrome. Int. J. Pediatr. Otorhinolaryngol. 2008, 72(6):841-847.
34. Blanchet C., Roux A.F., Hamel C., Ben Salah S., Artières F., Faugère V., et al. Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits. Rev. Laryngol. Otol. Rhinol. (Bord) 2007, 128(3):137-143.
35. Pennings R.J., Damen G.W., Snik A.F., Hoefsloot L., Cremers C.W., Mylanus E.A. Audiologic performance and benefit of cochlear implantation in Usher syndrome type I. Laryngoscope 2006, 116(5):717-722.
36. El-Amraoui A., Petit C. Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells. J. Cell Sci. 2005, 118(Pt 20):4593-4603.
37. Wagenaar M., Schuknecht H., Nadol J., Benraad-Van Rens M., Pieke-Dahl S., Kimberling W., et al. Histopathologic features of the temporal bone in Usher syndrome type I. Arch. Otolaryngol. Head Neck Surg. 2000, 126(8):1018-1023.
38. Konradsson K.S., Magnusson M., Linde G. Usher's syndrome and cochlear implant. Laryngoscope 1997, 107(3):406-407.
39. Young N.M., Johnson J.C., Mets M.B., Hain T.C. Cochlear implants in young children with Usher's syndrome. Ann. Otol. Rhinol. Laryngol. Suppl. 1995, 166:342-345.
40. Damen G.W., Pennings R.J., Snik A.F., Mylanus E.A. Quality of life and cochlear implantation in Usher syndrome type I. Laryngoscope 2006, 116(5):723-728.
41. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290(5806):457-465.
42. Cortopassi G., Hutchin T. A molecular and cellular hypothesis for aminoglycoside-induced deafness. Hear Res. 1994, 78(1):27-30.
43. Sinnathuray A.R., Raut V., Awa A., Magee A., Toner J.G. A review of cochlear implantation in mitochondrial sensorineural hearing loss. Otol. Neurotol. 2003, 24(3):418-426.
44. Huizing E.H., de Groot J.C. Human cochlear pathology in aminoglycoside ototoxicity - a review. Acta Otolaryngol. Suppl. 1987, 436:117-125.
45. Yamasoba T., Tsukuda K., Oka Y., Kobayashi T., Kaga K. Cochlear histopathology associated with mitochondrial transfer RNA(leu(UUR)) gene mutation. Neurology 1999, 52(8):1705-1707.
46. Prezant T.R., Agapian J.V., Bohlman M.C., Bu X., Oztas S., Qiu W.Q., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993, 4(3):289-294.
47. Tono T., Ushisako Y., Kiyomizu K., Usami S., Abe S., Shinkawa H., et al. Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial mutation. Am. J. Otol. 1998, 19(6):754-757.
48. Ulubil S.A., Furze A.D., Angeli S.I. Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial DNA mutation and no history of aminoglycoside exposure. J. Laryngol. Otol. 2006, 120(3):230-232.
49. Rosenthal E.L., Kileny P.R., Boerst A., Telian S.A. Successful cochlear implantation in a patient with MELAS syndrome. Am. J. Otol. 1999, 20(2):187-190. discussion 190-191.
50. Yasumura S., Aso S., Fujisaka M., Watanabe Y. Cochlear implantation in a patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes syndrome. Acta Otolaryngol. 2003, 123(1):55-58.
51. Karkos P.D., Anari S., Johnson I.J. Cochlear implantation in patients with MELAS syndrome. Eur. Arch. Otorhinolaryngol. 2005, 262(4):322-324.
52. Raut V., Sinnathuray A.R., Toner J.G. Cochlear implantation in maternal inherited diabetes and deafness syndrome. J. Laryngol. Otol. 2002, 116(5):373-375.
53. Counter P.R., Hilton M.P., Webster D., Wardell T., Taylor R.W., Besley G., et al. Cochlear implantation of a patient with a previously undescribed mitochondrial DNA defect. J. Laryngol. Otol. 2001, 115(9):730-732.
54. Waardenburg P.J. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am. J. Hum. Genet. 1951, 3(3):195-253.
55. Liu X.Z., Newton V.E., Read A.P. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am. J. Med. Genet. 1995, 55(1):95-100.
56. Cullen R.D., Zdanski C., Roush P., Brown C., Teagle H., Pillsbury H.C., et al. Cochlear implants in Waardenburg syndrome. Laryngoscope 2006, 116(7):1273-1275.
57. Nayak C.S., Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann. Otol. Rhinol. Laryngol. 2003, 112(9 Pt 1):817-820.
58. Watanabe A., Takeda K., Ploplis B., Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet. 1998, 18(3):283-286.
59. Moon S.K., Choi H.S., Lee S.J., Choung Y.H., Park K. Cochlear implantation in a case with Waardenburg syndrome. Cochlear Implants Int. 2004, 5(Suppl 1):212-214.
60. Nakashima S., Sando I., Takahashi H., Hashida Y. Temporal bone histopathologic findings of Waardenburg's syndrome: a case report. Laryngoscope 1992, 102(5):563-567.
61. Takasaki K., Balaban C.D., Sando I. Histopathologic findings of the inner ears with alport, Usher and Waardenburg syndromes. Adv. Otorhinolaryngol. 2000, 56:218-232.
62. Newton V. Hearing loss and Waardenburg's syndrome: Implications for genetic counselling. J. Laryngol. Otol. 1990, 104(2):97-103.
63. Oysu C., Baserer N., Tinaz M. Audiometric manifestations of Waardenburg's syndrome. Ear Nose Throat J. 2000, 79(9):704-709.
64. Oysu C., Oysu A., Aslan I., Tinaz M. Temporal bone imaging findings in Waardenburg's syndrome. Int. J. Pediatr. Otorhinolaryngol. 2001, 58(3):215-221.
65. Daneshi A., Hassanzadeh S., Farhadi M. Cochlear implantation in children with Waardenburg syndrome. J. Laryngol. Otol. 2005, 119(9):719-723.
66. Pau H., Gibson W.P., Gardner-Berry K., Sanli H. Cochlear implantations in children with Waardenburg syndrome: an electrophysiological and psychophysical review. Cochlear Implants Int. 2006, 7(4):202-206.
67. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am. Heart J. 1957, 54(1):59-68.
68. Siem G., Fruh A., Leren T.P., Heimdal K., Teig E., Harris S. Jervell and lange-nielsen syndrome in norwegian children: aspects around cochlear implantation, hearing, and balance. Ear Hear. 2008, 29(2):261-269.
69. Daneshi A., Ghassemi M.M., Talee M., Hassanzadeh S. Cochlear implantation in children with jervell, lange-nielsen syndrome. J. Laryngol. Otol. 2008, 122(3):314-317.
70. Chorbachi R., Graham J.M., Ford J., Raine C.H. Cochlear implantation in jervell and lange-nielsen syndrome. Int. J. Pediatr. Otorhinolaryngol. 2002, 66(3):213-221.
71. Schwartz P.J., Spazzolini C., Crotti L., Bathen J., Amlie J.P., Timothy K., et al. The jervell and lange-nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006, 113(6):783-790.
72. Kies S.J., Pabelick C.M., Hurley H.A., White R.D., Ackerman M.J. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005, 102(1):204-210.
73. Yanmei F., Yaqin W., Haibo S., Huiqun Z., Zhengnong C., Dongzhen Y., et al. Cochlear implantation in patients with jervell and lange-nielsen syndrome, and a review of literature. Int. J. Pediatr. Otorhinolaryngol. 2008, 72(11):1723-1729.
74. Neyroud N., Tesson F., Denjoy I., Leibovici M., Donger C., Barhanin J., et al. A novel mutation in the potassium channel gene KVLQT1 causes the jervell and lange-nielsen cardioauditory syndrome. Nat. Genet. 1997, 15(2):186-189.
75. Friedmann I., Fraser G.R., Froggatt P. Pathology of the ear in the cardioauditory syndrome of jervell and lange-nielsen (recessive deafness with electrocardiographic abnormalities). J. Laryngol. Otol. 1966, 80(5):451-470.
76. Friedmann I., Fraser G.R., Froggatt P. Pathology of the ear in the cardio-auditory syndrome of jervell and lange-nielsen. Report of a third case with an appendix on possible linkage with the rh blood group locus. J. Laryngol. Otol. 1968, 82(10):883-896.
77. Green J.D., Schuh M.J., Maddern B.R., Haymond J., Helffrich R.A. Cochlear implantation in jervell and lange-nielsen syndrome. Ann. Otol. Rhinol. Laryngol. Suppl. 2000, 185:27-28.